Penalization and shrinkage methods produced unreliable clinical prediction models especially when sample size was small.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
04 2021
Historique:
received: 19 06 2020
revised: 15 11 2020
accepted: 02 12 2020
pubmed: 12 12 2020
medline: 29 9 2021
entrez: 11 12 2020
Statut: ppublish

Résumé

When developing a clinical prediction model, penalization techniques are recommended to address overfitting, as they shrink predictor effect estimates toward the null and reduce mean-square prediction error in new individuals. However, shrinkage and penalty terms ('tuning parameters') are estimated with uncertainty from the development data set. We examined the magnitude of this uncertainty and the subsequent impact on prediction model performance. This study comprises applied examples and a simulation study of the following methods: uniform shrinkage (estimated via a closed-form solution or bootstrapping), ridge regression, the lasso, and elastic net. In a particular model development data set, penalization methods can be unreliable because tuning parameters are estimated with large uncertainty. This is of most concern when development data sets have a small effective sample size and the model's Cox-Snell R Penalization methods are not a 'carte blanche'; they do not guarantee a reliable prediction model is developed. They are more unreliable when needed most (i.e., when overfitting may be large). We recommend they are best applied with large effective sample sizes, as identified from recent sample size calculations that aim to minimize the potential for model overfitting and precisely estimate key parameters.

Identifiants

pubmed: 33307188
pii: S0895-4356(20)31209-9
doi: 10.1016/j.jclinepi.2020.12.005
pmc: PMC8026952
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-96

Subventions

Organisme : Cancer Research UK
ID : C49297/A27294
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T025085/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Stat Med. 2012 May 20;31(11-12):1150-61
pubmed: 21997569
J Clin Epidemiol. 2016 Jun;74:167-76
pubmed: 26772608
Stat Med. 2019 Mar 30;38(7):1276-1296
pubmed: 30357870
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Stat Med. 2019 Sep 20;38(21):4051-4065
pubmed: 31270850
BMJ. 2015 Aug 11;351:h3868
pubmed: 26264962
Med Decis Making. 2001 Jan-Feb;21(1):45-56
pubmed: 11206946
Stat Med. 1990 Nov;9(11):1303-25
pubmed: 2277880
Stat Med. 2013 Jul 20;32(16):2747-66
pubmed: 23303608
Stat Med. 2019 Mar 30;38(7):1262-1275
pubmed: 30347470
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Stat Med. 2014 Jul 10;33(15):2585-96
pubmed: 24549725
Stat Methods Med Res. 1997 Jun;6(2):167-83
pubmed: 9261914
BMJ. 2020 Mar 18;368:m441
pubmed: 32188600
Stat Med. 2016 Jan 30;35(2):214-26
pubmed: 26553135
Stat Methods Med Res. 2020 Nov;29(11):3166-3178
pubmed: 32401702
Bioinformatics. 2005 May 1;21(9):1979-86
pubmed: 15691862

Auteurs

Richard D Riley (RD)

Centre for Prognosis Research, School of Medicine, Keele University, Staffordshire, UK, ST5 5BG. Electronic address: r.riley@keele.ac.uk.

Kym I E Snell (KIE)

Centre for Prognosis Research, School of Medicine, Keele University, Staffordshire, UK, ST5 5BG.

Glen P Martin (GP)

Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Rebecca Whittle (R)

Centre for Prognosis Research, School of Medicine, Keele University, Staffordshire, UK, ST5 5BG.

Lucinda Archer (L)

Centre for Prognosis Research, School of Medicine, Keele University, Staffordshire, UK, ST5 5BG.

Matthew Sperrin (M)

Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Gary S Collins (GS)

Nuffield Department of Orthopaedics, Centre for Statistics in Medicine, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, OX3 7LD; NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH